PolyPid
Logotype for PolyPid Ltd

PolyPid (PYPD) investor relations material

PolyPid 2nd Annual Lytham Partners Healthcare Investor Summit summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for PolyPid Ltd
2nd Annual Lytham Partners Healthcare Investor Summit summary15 Jan, 2026

Platform technology and pipeline

  • Developing a unique platform for prolonged, linear local drug delivery, combining polymers and lipids in a self-assembling matrix.

  • Over 170 patents protect the technology, with headquarters in New Jersey and Israel.

  • Lead asset D-PLEX 100 is in late-stage development, with NDA submission planned for early this year.

  • Pipeline includes a GLP-1 program, with preclinical and efficacy data expected later this year.

Clinical results and regulatory progress

  • D-PLEX 100 targets the large U.S. surgical site infection market, covering 12 million procedures annually.

  • Phase 3 trial in colorectal resection showed a 40% reduction in infection, mortality, and re-intervention rates (from 18% to 9.9%).

  • Statistically significant results across all primary and secondary endpoints, including a drop in infection rate from 10% to 3.8%.

  • Achieved 60% reduction in severe sepsis scores and maintained robust results in minimally invasive procedures.

  • Pre-NDA meeting with FDA resulted in alignment on approval and submission process; NDA submission imminent.

Commercialization and market strategy

  • Product has breakthrough therapy, fast track, and QIDP designations, making it eligible for priority review and a six-month FDA review period.

  • Commercial launch planned with a U.S. partner; discussions are ongoing and announcement expected around NDA submission.

  • Hospitals bear direct costs of surgical site infections and face CMS penalties, making cost-saving solutions attractive.

  • Eligible for NTAP program, providing additional hospital reimbursement in the first 2-3 years post-launch.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next PolyPid earnings date

Logotype for PolyPid Ltd
Q4 202511 Feb, 2026
PolyPid
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next PolyPid earnings date

Logotype for PolyPid Ltd
Q4 202511 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

PolyPid Ltd. is a late-stage biopharmaceutical company focused on enhancing surgical outcomes through innovative drug delivery systems. The company's proprietary PLEX (Polymer-Lipid Encapsulation Matrix) technology is designed to enable localized, prolonged, and controlled release of active pharmaceutical ingredients at the surgical site. This technology aims to optimize therapeutic efficacy and minimize side effects by maintaining a consistent drug presence over an extended period. The company is headquartered in Petach Tikva, Israel, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage